`

Karyopharm Therapeutics Inc

Pharmaceutical Manufacturing

Specialities :
Oncology
Pharmaceutical
Biotech
Multiplemyeloma
Lymphoma

+7

revenue-icon Revenue
101M - 500M
funding-icon Total Funding
$165.0M
size-icon Size
201 - 500

Frequently Asked Questions About Karyopharm Therapeutics Inc

What does Karyopharm therapeutics inc do?+

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL)

What are Karyopharm therapeutics inc's specialties? +

Oncology,pharmaceutical,biotech,multiplemyeloma,lymphoma,solidtumors,clinicalresearch,clinicaltrials,research,drugdiscovery,medical,and healthcare

What is Karyopharm therapeutics inc's industry? +

Karyopharm therapeutics inc operates in the Pharmaceutical manufacturing industry.

What is Karyopharm therapeutics inc's revenue? +

Karyopharm therapeutics inc's revenue is 101m - 500m

What is Karyopharm therapeutics inc's company size? +

Karyopharm therapeutics inc has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.